Factor XI inhibitors in patients with cardiovascular disease and a high risk of bleeding: a cautionary tale

Nat Rev Cardiol. 2023 Aug;20(8):511-512. doi: 10.1038/s41569-023-00872-4.

Bruna Gigante^{1

2}, Hugo Ten Cate^{3

4

5

6}

¹ Division of Cardiovascular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
² Department of Cardiology, Danderyd University Hospital, Stockholm, Sweden.
³ Thrombosis Expert Center, Maastricht University Medical Center (MUMC+), Maastricht, Netherlands. h.tencate@maastrichtuniversity.nl.
⁴ Departments of Internal Medicine and Biochemistry, Maastricht University Medical Center (MUMC+), Maastricht, Netherlands. h.tencate@maastrichtuniversity.nl.
⁵ CARIM School for Cardiovascular Research, Maastricht, Netherlands. h.tencate@maastrichtuniversity.nl.
⁶ Center for Thrombosis and Hemostasis, Gutenberg University Medical Center, Mainz, Germany. h.tencate@maastrichtuniversity.nl.

No abstract available

MeSH terms